1. Université de Lorraine, Inserm, Centre d’Investigations Cliniques-Plurithématique 14–33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).
2. Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Portugal (J.P.F.).
3. Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).
4. Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.V., P.W.).
5. London School of Hygiene and Tropical Medicine, United Kingdom (T.C.).
6. Inserm 1024, Institut de Biologie de l’École Normale Supérieure (IBENS), PSL University of Paris, France (A.P.).
7. Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany (C.B., T.T.).
8. Casa di Cura Quisisana, Rome, Italy (A.B.).
9. TATAA Biocenter AB, Gothenburg, Sweden (J.B.).
10. Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B.).
11. Excellence Cluster REBIRTH, Hannover Medical School, Germany (J.B.).
12. Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom (A.C.).
13. Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, Glasgow, United Kingdom (J.G.C.).
14. National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, University of Glasgow, London, United Kingdom (J.G.C.).
15. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, United Kingdom (C.D.).
16. Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D., A.G.).
17. CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D., A.G.).
18. Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain (J.D., A.G.).
19. Departments of Nephrology, and Cardiology and Cardiac Surgery, University of Navarra Clinic, Pamplona, Spain (J.D.).
20. Department of Cardiology, Leiden University Medical Center, the Netherlands (W.J.).
21. IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (R.L.).
22. ACS Biomarker BV, Amsterdam, the Netherlands (J.L.).
23. National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, MA (D.L.).
24. Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L.). UMRS 942, University Paris Diderot
25. APHP, University Hospitals Saint Louis Lariboisière, France (A.M., N.V.).
26. Mosaiquesdiagnostics, Hannover, Germany (H.M.).
27. Inserm U1167, Institut Pasteur de Lille, Université de Lille, FHU-REMOD-VHF, France (F.P.).
28. Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (N.S.).
29. International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, England (P.S.).
30. Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S., Z.-Y.Z.).
31. Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands (J.A.S.).
32. National Heart and Lung Institute, Imperial College London, United Kingdom (T.T.).
33. Department of Cardiovascular Research, University of Leuven, Belgium (S.H.). Netherlands Heart Institute (ICIN), Utrecht, the Netherlands (S.H.).